Use the Back button in your browser to see the other results of your search or to select another record.
A comparison of the efficacy of Darifenacin alone versus Darifenacin plus a behavioural modification programme upon the symptoms of overactive bladder [with consumer summary] |
Chancellor MB, Kianifard F, Beamer E, Mongay L, Ebinger U, Hicks G, Delconte A |
International Journal of Clinical Practice 2008 Apr;62(4):606-613 |
clinical trial |
6/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
Copyright release for this abstract has not been granted.
|